Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FAIRCLOTH, G. T")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 21 of 21

  • Page / 1
Export

Selection :

  • and

A adjustable microplate platformFAIRCLOTH, G. T; YOUNG, M.Journal of tissue culture methods. 1989, Vol 12, Num 2, pp 61-62, issn 0271-8057Article

A high capacity microplate rackFAIRCLOTH, G. T; NEWMAN, D; YOUNG, M et al.Journal of tissue culture methods. 1989, Vol 12, Num 2, pp 63-65, issn 0271-8057Article

A simple screening procedure for the quantitative measurement of cytotoxicity to resting primary lymphocyte culturesFAIRCLOTH, G. T; STEWART, D; CLEMENT, J. J et al.Journal of tissue culture methods. 1988, Vol 11, Num 4, pp 201-205, issn 0271-8057Article

New acetylenic alcohols from the sponge Cribrochalina vasculumGUNASEKERA, S. P; FAIRCLOTH, G. T.Journal of organic chemistry. 1990, Vol 55, Num 25, pp 6223-6225, issn 0022-3263, 3 p.Article

A nondisposable microplate for use with organic solventsCROSS, S. S; FAIRCLOTH, G. T; YOUNG, M et al.Journal of tissue culture methods. 1989, Vol 12, Num 2, pp 57-59, issn 0271-8057Article

Metabolism of luteinizing hormone by the pseudopregnant rat ovaryRORKE, E. A; FAIRCLOTH, G. T; VAITUKAITIS, J. L et al.Endocrinology (Philadelphia). 1984, Vol 115, Num 3, pp 962-968, issn 0013-7227Article

Differential subcellular distribution of bioactive human chorionic gonadotropin in pseudopregnant rat ovaryGILLIGAN, A; KAWAMURA, H; FAIRCLOTH, G. T et al.Endocrinology (Philadelphia). 1986, Vol 119, Num 1, pp 97-104, issn 0013-7227Article

Evaluation of the use of in vitro methodologies as tools for screening new compounds for potential in vivo toxicityLUBER-NAROD, J; SMITH, B; GRANT, W et al.Toxicology in vitro. 2001, Vol 15, Num 4-5, pp 571-577, issn 0887-2333Conference Paper

In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effectsSIMOENS, C; KORST, A. E. C; DE POOTER, C. M. J et al.British journal of cancer. 2003, Vol 89, Num 12, pp 2305-2311, issn 0007-0920, 7 p.Article

High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancerHENDRIKS, H. R; FIEBIG, H. H; GIAVAZZI, R et al.Annals of oncology. 1999, Vol 10, Num 10, pp 1233-1240, issn 0923-7534Article

Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of actionERBA, E; BERGAMASCHI, D; BASSANO, L et al.European journal of cancer (1990). 2001, Vol 37, Num 1, pp 97-105, issn 0959-8049Article

In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cellsDEPENBROCK, H; PETER, R; FAIRCLOTH, G. T et al.British journal of cancer. 1998, Vol 78, Num 6, pp 739-744, issn 0007-0920Article

In vivo immunosuppressive activity of some cyclolignansGORDALIZA, M; CASTRO, M. A; DEL CORRAL, J. M. M et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 21, pp 2781-2786, issn 0960-894XArticle

The unique biological features of the marine product Yondelis (ET-743, Trabectedin) are shared by its analog ET-637, which lacks the C ringERBA, E; CAVALLARO, E; DAMIA, G et al.Oncology research. 2004, Vol 14, Num 11-12, pp 579-587, issn 0965-0407, 9 p.Article

Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4BROGGINI, M; MARCHINI, S. V; D'INCALCI, M et al.Leukemia. 2003, Vol 17, Num 1, pp 52-59, issn 0887-6924, 8 p.Article

Effect of Aplidin in acute lymphoblastic leukaemia cellsERBA, E; SERAFINI, M; BIONDI, A et al.British journal of cancer. 2003, Vol 89, Num 4, pp 763-773, issn 0007-0920, 11 p.Article

Immunosuppressive cyclolignansGORDALIZA, M; FAIRCLOTH, G. T; CASTRO, M. A et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 14, pp 2865-2868, issn 0022-2623Article

Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743MARCHINI, S; MARRAZZO, E; BONOMI, R et al.European journal of cancer (1990). 2005, Vol 41, Num 2, pp 323-333, issn 0959-8049, 11 p.Article

Antiangiogenic activity of aplidine, a new agent of marine originTARABOLETTI, G; POLI, M; DOSSI, R et al.British journal of cancer. 2004, Vol 90, Num 12, pp 2418-2424, issn 0007-0920, 7 p.Article

In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical developmentBRESTERS, D; BROEKHUIZEN, A. J. F; KAAIJK, P et al.Leukemia. 2003, Vol 17, Num 7, pp 1338-1343, issn 0887-6924, 6 p.Article

Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assaysGELDOF, A. A; MASTBERGEN, S. C; HENRAR, R. E. C et al.Cancer chemotherapy and pharmacology. 1999, Vol 44, Num 4, pp 312-318, issn 0344-5704Article

  • Page / 1